Sudden Cardiac Arrest During the Immediate Revascularization Period in Patients With Non-ST Elevation Myocardial Infarction: A Case Series.


Journal

Cardiovascular revascularization medicine : including molecular interventions
ISSN: 1878-0938
Titre abrégé: Cardiovasc Revasc Med
Pays: United States
ID NLM: 101238551

Informations de publication

Date de publication:
07 2022
Historique:
received: 18 08 2021
revised: 03 11 2021
accepted: 16 11 2021
pubmed: 25 11 2021
medline: 16 8 2022
entrez: 24 11 2021
Statut: ppublish

Résumé

The timing of sudden cardiac arrest (SCA) after myocardial infarction (MI) has been a subject of research because of the impact on preventive strategies. Currently, there is limited data on the risk of SCA in the immediate post revascularization period (≤48 h) in non-ST segment elevation myocardial infarction (NSTEMI). We retrospectively reviewed the electronic medical record system and identified patients who underwent revascularization for NSTEMI at Grady Memorial Hospital, Atlanta, Georgia between January 1st, 2014-December 31st, 2019. We selected patients who had SCA within 48 h of revascularization and evaluated their socio-demographic and inpatient characteristics and outcomes. Sixteen (16) cases of SCA in the immediate post revascularization period (within 48 h) were identified and analyzed which corresponds to an incidence rate of 1.8% (n = 16/869). The mean age (SD) was 69 years (14.6) and 75% were males. On angiography, more than 80% of the patients had hemodynamically significant lesions in the left anterior descending arteries and its territories and 50% had multivessel disease. All 16 patients had at least one coronary artery with hemodynamically significant lesion and successfully underwent revascularization. Three-quarter of the patients had a shockable rhythm. The etiology of SCA was in-stent thrombosis in 25% of the patients, cardiogenic shock in 19%, acute respiratory failure in 13% and unknown in 44% of the cases. The 30-day mortality rate was 38%. The rate of SCA is high in the first 48 h after MI even with revascularization. Risk stratification for SCA during this critical period may improve outcomes.

Identifiants

pubmed: 34815183
pii: S1553-8389(21)00746-6
doi: 10.1016/j.carrev.2021.11.019
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

332-336

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors of this manuscript have no financial disclosure or conflict of interests to report. All authors contributed to the writing of the manuscript.

Auteurs

Titilope Olanipekun (T)

Department of Hospital Medicine, Covenant Health System, Knoxville, TN, USA; Department of Internal Medicine, Morehouse School of Medicine, Atlanta, GA, USA; Safety, Quality, Informatics and Leadership Program, Department of Postgraduate Education, Harvard Medical School, Boston, MA, USA. Electronic address: titilope_olanipekun@teamhealth.com.

Temidayo Abe (T)

Department of Internal Medicine, Morehouse School of Medicine, Atlanta, GA, USA.

Joseph Igwe (J)

Department of Internal Medicine, Morehouse School of Medicine, Atlanta, GA, USA.

Valery Effoe (V)

Department of Internal Medicine, Morehouse School of Medicine, Atlanta, GA, USA; Division of Cardiology, Morehouse School of Medicine, Atlanta, GA, USA.

Obiorah Egbuche (O)

Department of Internal Medicine, Morehouse School of Medicine, Atlanta, GA, USA; Division of Cardiology, Morehouse School of Medicine, Atlanta, GA, USA; Department of Interventional Cardiology, Ohio State University, Columbus, OH, USA.

Abimbola Chris-Olaiya (A)

Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, OH, USA.

Richard Snyder (R)

Department of Internal Medicine, Morehouse School of Medicine, Atlanta, GA, USA; Division of Pulmonary and Critical Care Medicine, Morehouse School of Medicine, Atlanta, GA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH